Burrill Brazil Fund I

The fund invests in the life sciences in Brazil, including early- to late-stage investments in
therapeutics, diagnostics, medical devices, healthcare services, biofuels and digital health. The fund has $125 million in capital commitments and is expected to reach $200 million at final close.